269. Pyogenic arthritis
20 clinical trials,   26 drugs   (DrugBank: 10 drugs),   12 drug target genes,   90 drug target pathways
Searched query = "Pyogenic arthritis", "Pyoderma gangrenosum", "Acne syndrome", "PAPA syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT03971643 (ClinicalTrials.gov) | May 16, 2019 | 28/5/2019 | Exploratory Study of IFX-1 in Subjects With Pyoderma Gangrenosum | Open Label Exploratory Phase 2a Trial to Investigate the Safety and Efficacy of IFX-1 in Treating Subjects With Pyoderma Gangrenosum (Optima) | Pyoderma Gangrenosum | Drug: IFX-1 | InflaRx GmbH | Innovaderm Research Inc. | Recruiting | 18 Years | N/A | All | 18 | Phase 2 | United States;Canada |